scholarly article | Q13442814 |
P50 | author | Ryan Jordan Stark | Q50073010 |
P2093 | author name string | Hyehun Choi | |
Edward Sherwood | |||
Stephen Koch | |||
Fred Lamb | |||
P2860 | cites work | Induction of cyclooxygenase-2 by the activated MEKK1 --> SEK1/MKK4 --> p38 mitogen-activated protein kinase pathway | Q28270455 |
TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-beta | Q28506630 | ||
Toll-like receptor 4 and Toll-IL-1 receptor domain-containing adapter protein (TIRAP)/myeloid differentiation protein 88 adapter-like (Mal) contribute to maximal IL-6 expression in macrophages | Q28508577 | ||
The attenuated inflammation of MPL is due to the lack of CD14-dependent tight dimerization of the TLR4/MD2 complex at the plasma membrane | Q28587156 | ||
CD14 controls the LPS-induced endocytosis of Toll-like receptor 4 | Q28594101 | ||
Endocytic pathways regulate Toll-like receptor 4 signaling and link innate and adaptive immunity | Q30476891 | ||
Mechanisms of the TRIF-induced interferon-stimulated response element and NF-kappaB activation and apoptosis pathways | Q33197029 | ||
Differential induction of the toll-like receptor 4-MyD88-dependent and -independent signaling pathways by endotoxins | Q33769086 | ||
Endothelium function in sepsis | Q33967400 | ||
Structural and functional analyses of bacterial lipopolysaccharides. | Q34727370 | ||
The Toll-like receptor 4 agonist monophosphoryl lipid a augments innate host resistance to systemic bacterial infection | Q35191988 | ||
MyD88-dependent SHIP1 regulates proinflammatory signaling pathways in dendritic cells after monophosphoryl lipid A stimulation of TLR4. | Q35644967 | ||
Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14 | Q36197092 | ||
Myeloid differentiation factor 88-independent Toll-like receptor pathway: Sustaining inflammation or promoting tolerance? | Q36850443 | ||
Ability of monophosphoryl lipid A to augment the antibody response of young mice | Q37001547 | ||
The immunobiology of toll-like receptor 4 agonists: from endotoxin tolerance to immunoadjuvants | Q37572673 | ||
Inhibition of endocytosis exacerbates TNF-α-induced endothelial dysfunction via enhanced JNK and p38 activation | Q39021598 | ||
Lipopolysaccharide-binding protein-mediated Toll-like receptor 4 dimerization enables rapid signal transduction against lipopolysaccharide stimulation on membrane-associated CD14-expressing cells | Q39743477 | ||
Cell biology of endothelial cells | Q39758344 | ||
Serum stimulates Pleiotrophin gene expression in an AP-1-dependent manner in human endothelial and glioblastoma cells. | Q39866670 | ||
Role for MyD88-independent, TRIF pathway in lipid A/TLR4-induced endotoxin tolerance | Q40085281 | ||
The vaccine adjuvant monophosphoryl lipid A as a TRIF-biased agonist of TLR4. | Q40203530 | ||
Monophosphoryl lipid A (MPL) promotes allergen-induced immune deviation in favour of Th1 responses. | Q40511372 | ||
Induction of in vitro reprogramming by Toll-like receptor (TLR)2 and TLR4 agonists in murine macrophages: effects of TLR "homotolerance" versus "heterotolerance" on NF-kappa B signaling pathway components | Q40681768 | ||
Possible involvement of toll-like receptor 4 in endothelial cell activation of larger vessels in response to lipopolysaccharide | Q40692335 | ||
A study of the cellular and molecular mediators of the adjuvant action of a nontoxic monophosphoryl lipid A. | Q41203336 | ||
Geniposide inhibits interleukin-6 and interleukin-8 production in lipopolysaccharide-induced human umbilical vein endothelial cells by blocking p38 and ERK1/2 signaling pathways | Q43187717 | ||
CD14 is required for MyD88-independent LPS signaling. | Q45990170 | ||
Lipid A and immunotherapy. | Q46536381 | ||
Potent phagocytic activity with impaired antigen presentation identifying lipopolysaccharide-tolerant human monocytes: demonstration in isolated monocytes from cystic fibrosis patients | Q47884000 | ||
Enhanced immunogenicity of a recombinant genital warts vaccine adjuvanted with monophosphoryl lipid A. | Q50128875 | ||
Lipopolysaccharide induces the rapid tyrosine phosphorylation of the mitogen-activated protein kinases erk-1 and p38 in cultured human vascular endothelial cells requiring the presence of soluble CD14. | Q53007167 | ||
Toll-like receptor 4 is involved in bacterial endotoxin-induced endothelial cell injury and SOC-mediated calcium regulation. | Q53674487 | ||
The cardiovascular response of normal humans to the administration of endotoxin. | Q54346884 | ||
MPLA inhibits release of cytotoxic mediators from human neutrophils while preserving efficient bacterial killing. | Q55073266 | ||
Atorvastatin suppresses LPS-induced rapid upregulation of Toll-like receptor 4 and its signaling pathway in endothelial cells | Q83402792 | ||
TLR4 Activation Induces Nontolerant Inflammatory Response in Endothelial Cells | Q85106696 | ||
P433 | issue | 6 | |
P921 | main subject | endothelium | Q111140 |
P304 | page(s) | 565-574 | |
P577 | publication date | 2014-12-24 | |
P1433 | published in | Innate Immunity | Q6035271 |
P1476 | title | Monophosphoryl lipid A inhibits the cytokine response of endothelial cells challenged with LPS | |
P478 | volume | 21 |
Q36634934 | Association of O-Antigen Serotype with the Magnitude of Initial Systemic Cytokine Responses and Persistence in the Urinary Tract |
Q90113588 | BMP-9 Modulates the Hepatic Responses to LPS |
Q36552355 | Endothelial cell tolerance to lipopolysaccharide challenge is induced by monophosphoryl lipid A. |
Q50072965 | Endothelial nitric oxide synthase modulates Toll-like receptor 4-mediated IL-6 production and permeability via nitric oxide-independent signaling |
Q92069078 | In situ vaccination with defined factors overcomes T cell exhaustion in distant tumors |
Q91693700 | Monophosphoryl Lipid a Attenuates Multiorgan Dysfunction During Post-Burn Pseudomonas Aeruginosa Pneumonia in Sheep |
Q46412054 | Potentiation and tolerance of toll-like receptor priming in human endothelial cells |
Search more.